Table 1.
Coagulation screening profile
| Basic profile | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PT | APTT | INR | Antithrombin | Fibrinogen | D-Dimer | ||||
| 10.5 | 26 |
0.93 (0.8–1–2) |
111% (n.v. 80–120) |
785 mg/DL* (n.v. 150–400) |
188 ng/mL* (n.v. 0–500) |
||||
| Advanced first level | |||||||||
| Protein C | Protein S | Homocysteine | Anti Xa | ||||||
|
95 (n.v. 70–140) |
104.5 (n.v. 74–146) |
31.3 mcmol/L* (n.v. 4–11) |
0.39 U/mL (n.v. 0.2–0.4) |
||||||
| Advanced second level | |||||||||
|
Factor II 20210G/20210A |
Factor V 1691G/1691A |
Lupus anticoagulant (dRVVT) |
Antiphospholipid antibody syndrome (APS) Antibodies |
||||||
| Heterozygote mutation | Absent |
1.13 (Ratio 0–1.2) |
Anti-cardiolipin IgG |
Anti-cardiolipin IgM |
Anti-Neta2Gp1 IgG |
Anti-Neta2Gp1 IgM |
|||
|
0.8 (n.v. 0–10) |
0.7 (n.v. 0–7) |
0.7 (n.v. 0–5) |
1.2 (n.v. 0–5) |
||||||
*bold values are the ones out of range